Augmentation strategies with serotonergic-noradrenergic combinations

Journal of Clinical Psychiatry

Volumn 59, Issue SUPPL. 5, 1998, Pages 65-69

  Nelson, J Craig ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Psychiatry ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CLOMIPRAMINE; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE MALEATE; MIRTAZAPINE; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ARTICLE; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; HUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; SEROTONINERGIC NERVE CELL;

EID: 0031865436     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Danish University Antidepressant Group. Citalopram: clinical effect profile in comparison with clomipramine: a controlled multicenter study. Psychopharmacology (Berl) 1986;90:131-138
2. Danish University Antidepressant Group. Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. J Affect Disord 1990;18:289-299
3. Anderson I, Tomenson B. A meta-analysis of the efficacy of selective serotonin reuptake inhibitors compared to tricyclic antidepressants in depression [abstract]. Neuropsychopharmacology 1994;10(suppl):106
4. Anderson I. SSRIs in depression: what can we learn from meta analysis. Presented at the 6th World Congress of Biological Psychiatry; June 23, 1997; Nice, France
5. Delgado PL, Charney DS, Price LH, et al. Serotonin function and the mechanism of antidepressant action: reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 1990;47:411-418
6. Delgado PL, Price LH, Miller HL, et al. Serotonin and the neurobiology of depression: effects of tryptophan depletion in drug-free depressed patients. Arch Gen Psychiatry 1994;51:865-874
7. Miller HL, Delgado P, Salomon R, et al. Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression. Arch Gen Psychiatry 1996;53:117-128
8. Weilburg JB, Rosenbaum JF, Biederman J, et al. Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report. J Clin Psychiatry 1989;50:447-449
9. Seth R, Jennings AL, Bindman J, et al. Combination treatment with noradrenaline and serotonin reuptake inhibitors in resistant depression. Br J Psychiatry 1992;161:562-565
10. Nelson JC, Mazure CM, Bowers MB, et al. A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Arch Gen Psychiatry 1991;48:303-307
11. Nelson JC, Jatlow P, Quinlan DM, et al. Desipramine plasma concentrations and antidepressant response. Arch Gen Psychiatry 1982;39: 1419-1422
12. Wernicke JF, Dunlop SR, Dornseif BE, et al. Fixed-dose fluoxetine therapy for depression. Psychopharmacol Bull 1987;23:164-168
13. Wernicke JF, Dunlop SR, Dornseif BE, et al. Free communications: depression; low-dose fluoxetine therapy for depression. Psychopharmacol Bull 1988;24:183-188
14. Dornseif BE, Dunlop SR, Potvin JH, et al. Effect of dose escalation after low-dose fluoxetine therapy. Psychopharmacol Bull 1989;25:71-79
15. Schweizer E, Rickels K, Amsterdam JD, et al. What constitutes an adequate antidepressant trial for fluoxetine? J Clin Psychiatry 1990;51:8-11
16. Fava M, Rosenbaum JF, Grossbard SJ, et al. Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double blind, controlled study. Am J Psychiatry 1994;151:1372-1374
17. Nelson JC, Price LH. Lithium or desipramine augmentation of fluoxetine treatment. Am J Psychiatry 1995;152:1538-1539
18. Boyer WF, Feighner JP. The combined use of fluoxetine and bupropion. In: New Research Program and Abstracts of the 146th annual meeting of the American Psychiatric Association; May 27, 1993; San Francisco, Calif. Abstract NR746:247
19. Bodkin JA, Lasser RA, Wines JD Jr, et al. Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy. J Clin Psychiatry 1997;58:137-145
20. Rosenstein DL, Nelson JC, Jacobs SC. Seizures associated with antidepressants: a review. J Clin Psychiatry 1993;54:289-299
21. Preskorn SH. Antidepressant response and plasma concentrations of bupropion. J Clin Psychiatry 1983;44(5, sec 2):137-139
22. Golden RN, DeVane CL, Laizure SC, et al. Bupropion in depression, part II: the role of metabolites in clinical outcome. Arch Gen Psychiatry 1988; 45:145-149
23. Goodnick PJ. Blood levels and acute response to bupropion. Am J Psychiatry 1992;149:399-400
24. Davidson J. Seizures and bupropion: a review. J Clin Psychiatry 1989;50: 256-261
25. Briley M, Montgomery S, eds. Antidepressant Therapy at the Dawn of the Third Millennium. London, England: Martin Dunitz; 1997